Meehan, K R <br/><br/>
Interleukin-2-activated hematopoietic stem cell transplantation for breast cancer: investigation of dose level with clinical correlates.  [electronic resource] 

 -  Bone marrow transplantation  Oct 1997 
 - 643-51 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>0268-3369 
<br/><br/><label>Standard No.: </label>10.1038/sj.bmt.1700954  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Breast Neoplasms--pathology<br/>Carboplatin--therapeutic use<br/>Cell Separation<br/>Combined Modality Therapy<br/>Cyclophosphamide--therapeutic use<br/>Female<br/>Flow Cytometry<br/>Hematopoiesis<br/>Hematopoietic Stem Cell Transplantation<br/>Hematopoietic Stem Cells--drug effects<br/>Humans<br/>Interleukin-2--administration & dosage<br/>Middle Aged<br/>Neoplasm Staging